GLP-1 Rebound Risk: A Cardiologist’s Plan to Keep Weight Off
In this video, Dr. Columbus Batiste, an interventional cardiologist, explains why “just taking the shot and eating less” is not a long-term strategy with GLP-1 medications and walks through a science-informed off-ramp plan to protect muscle, metabolism, and health markers when the drug is reduced or stopped; drawing on STEP 1 extension data and meta-analyses showing that patients often regain a substantial portion of lost weight and see A1C rise after discontinuation, he outlines a practical three-pillar approach—prioritizing plant-forward protein, gradually increasing fiber, and lifting weights—plus five off-ramp-friendly foods and a stepwise taper protocol so that when appetite returns, your habits and plate are already prepared to help maintain progress.
Timestamps
[0:00] – Why “just take the shot” is not a long-term GLP-1 plan
[1:33] – What happens after stopping GLP-1s: STEP 1 data and rebound patterns
[2:53] – The real threat: lean mass loss, smaller metabolism, and fat regain
[4:04] – The 3-pillar GLP-1 plate: protein floor, fiber ceiling, plant foundation
[7:12] – Top 5 off-ramp foods and the step-by-step GLP-1 taper protocol
I’m Dr. Columbus Batiste, a double board-certified Interventional Cardiologist, author of SELFISH.
My mission is to empower YOU to take control of your health.
Learn more at:
Grab a copy of my book SELFISH to start your journey:
FOLLOW ME:
Instagram: @healthyheartdoc
Twitter/X: @Iamhealthyheart
Linkedin: linkedin.com/in/drbatiste
Articles
Wilding, J. P. H., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., Lingvay, I., Oral, T. K., Rosenstock, J., Wadden, T. A., Wharton, S., Yokote, K., Kushner, R. F., & McGowan, B. M. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.147251
Tzang, C.-C., Wu, P.-H., Luo, C.-A., Chen, Z.-T., Lee, Y.-T., Huang, E. S., Kang, Y.-F., Lin, W.-C., Tzang, B.-S., & Hsu, T.-C. (2025). Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis. eClinicalMedicine, 90, 103680. https://doi.org/10.1016/j.eclinm.2025.103680
IMPORTANT NOTE: These strategies should be used as a complement to, not a replacement for, prescribed medications and a diverse plant-based diet rich in vegetables, legumes, fruits, and whole grains. Always consult your healthcare provider before making dietary changes, especially if you have existing cardiovascular conditions or are taking medications.
Disclaimer: The content on this channel is for general information and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. All viewers should consult their physician or qualified healthcare provider before starting any medical program, treatment, or making changes to their health regimen or diet. You should not use this information to self-diagnose or treat any health condition.
Comments